Head of the Intellectual Property Practice in Australia, Lisa Taliadoros has nearly 20 years of experience in high-value IP disputes, including in relation to patents, copyrights, and trademarks.
A focus of Lisa's practice is complex, multijurisdictional patent litigation in the Federal Court of Australia. She has acted across a range of industries, including pharmaceuticals, life sciences, biotechnology, mining, and building and construction. Lisa has acted in the High Court of Australia in two recent landmark decisions concerning the scope of patent protection for Myriad's BRCA1 (breast cancer) patents and Sanofi's leflunomide patent for the treatment of skin disorders and arthritic conditions. In addition, she has acted in the Federal Court of Australia for other large multinational pharmaceutical companies in matters relating to patents for new compounds, biologics, biosimilars, drug formulations, drug delivery devices, dental technology, and methods of treatment. She also has acted in matters concerning patents relating to mining tools and technologies (including deep water drilling apparatus) and building systems.
Lisa is a member of the Intellectual Property Law Subcommittee of the Law Council of Australia.
Prior to obtaining her law degree, Lisa was a scientist at two of Australia's preeminent research organizations, the CSIRO and the Centenary Institute of Cell Biology and Cancer Medicine. Her research projects involved the development of vaccines for avian infectious bronchitis virus and investigating the role of lymphotoxin alpha in the pathogenesis of autoimmune disorders.
Lisa is Partner-in-Charge of the Melbourne Office and serves as Jones Day's diversity partner for Australia.
Australian Court Holds That Use of a Corporate Logo for Purposes of Engaging in a Public Campaign Amounts to Mostly Fair Dealing
"Very thoughtful, detail-orientated and she really analyses issues deeply."Chambers Asia-Pacific
- University of New South Wales (LL.B. 1998); University of Sydney (Grad. Dip. Sc. 1996); Monash University (B.Sc. 1988)
- New South Wales
Best Lawyers in Australia (2014-2023): Biotechnology Law and Intellectual Property Law
Chambers Asia-Pacific (2019): "very thoughtful, detail-orientated and she really analyses issues deeply"
IP STARS: Patent star — Australia and Top 250 Women in IP
The Legal 500 Asia Pacific: IP law since 2016
Ranked as a top professional in the IAM Patent 1000 — The World's Leading Patent Practitioners since 2015
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice